UK markets closed

4DMedical Limited (4DX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.6100-0.0150 (-2.40%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
Total revenue
588.818
282.181
1,054
216.978
Cost of revenue
51.291
34.146
773.683
91.853
Gross profit
537.527
248.035
280.617
125.125
Operating expenses
Research development
-
4,037
-
2,358
Selling general and administrative
25,901
25,112
21,127
12,703
Total operating expenses
46,847
45,254
37,031
24,464
Operating income or loss
-46,309
-45,006
-36,751
-24,339
Interest expense
7.719
6.502
-
2,627
Total other income/expenses net
14,600
13,556
12,288
5,591
Income before tax
-30,468
-31,137
-24,550
-21,405
Income tax expense
366.969
323.222
43.208
15.308
Income from continuing operations
-30,835
-31,460
-24,593
-21,421
Net income
-30,835
-31,460
-24,593
-21,421
Net income available to common shareholders
-30,835
-31,460
-24,593
-21,421
Basic EPS
-0.10
-0.10
-0.12
-0.10
Diluted EPS
-0.10
-0.10
-0.12
-0.10
Basic average shares
300,014
300,014
208,956
207,167
Diluted average shares
300,014
300,014
208,956
207,167